Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: Possible prognostic differences

BJU International

Volumn 103, Issue 10, 2009, Pages 1349-1354

  Bedke, Jens ^a,c   Buse, Stephan ^a   Pritsch, Maria ^a   MacHer Goeppinger, Stephan ^b   Schirmacher, Peter ^b   Haferkamp, Axel ^a   Hohenfellner, Markus ^a  

^a Medical Biometry ^*

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Fat infiltration; Perirenal; Renal cell cancer; Renal sinus; Stage pT3a

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; FOLLOW UP; HISTOPATHOLOGY; HUMAN; KARNOFSKY PERFORMANCE STATUS; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NEPHRECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; ADIPOSE TISSUE; EPIDEMIOLOGY; FEMALE; KIDNEY TUMOR; LYMPH NODE METASTASIS; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY;

ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS;

EID: 66149147486     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08236.x     Document Type: Article

References (27)

1. Greene FL, Page D, Fleming ID et al. AJCC Cancer Staging Manuel, 6th edn. New York : Springer-Verlag, 2002
2. Ficarra V, Novara G, Galfano A, Artibani W. Neoplasm staging and organ-confined renal cell carcinoma: a systematic review. Eur Urol 2004 46 : 559 64
3. Steiner T, Knels R, Schubert J. Prognostic significance of tumour size in patients after tumour nephrectomy for localised renal cell carcinoma. Eur Urol 2004 46 : 327 30
4. Ficarra V, Guille F, Schips L et al. Proposal for revision of the TNM classification system for renal cell carcinoma. Cancer 2005 104 : 2116 23
5. Ficarra V, Novara G, Iafrate M et al. Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome. Eur Urol 2007 51 : 722 9
6. Ficarra V, Galfano A, Guille F et al. A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients. J Urol 2007 178 : 418 24
7. Bedke J, Pritsch M, Buse S et al. Prognostic stratification of localized renal cell carcinoma by tumor size. J Urol 2008 180 : 62 7
8. Klatte T, Patard JJ, Goel RH et al. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience. J Urol 2007 178 : 35 40
9. Lam JS, Klatte T, Patard JJ et al. Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experience. Eur Urol 2007 52 : 155 62
10. Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG. Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system. Cancer 2007 109 : 2439 44
11. Thompson RH, Leibovich BC, Cheville JC et al. Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? J Urol 2005 174 : 1218 21
12. Sandock DS, Seftel AD, Resnick MI. Adrenal metastases from renal cell carcinoma: role of ipsilateral adrenalectomy and definition of stage. Urology 1997 49 : 28 31
13. Thompson RH, Leibovich BC, Cheville JC et al. Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a? J Urol 2005 173 : 918 21
14. Siemer S, Lehmann J, Loch A et al. Current TNM classification of renal cell carcinoma evaluated: revising stage T3a. J Urol 2005 173 : 33 7
15. Gofrit ON, Shapiro A, Pizov G et al. Does stage T3a renal cell carcinoma embrace a homogeneous group of patients? J Urol 2007 177 : 1682 6
16. Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. J Urol 2007 178 : 1878 82
17. Thompson RH, Blute ML, Krambeck AE et al. Patients with pT1 renal cell carcinoma who die from disease after nephrectomy may have unrecognized renal sinus fat invasion. Am J Surg Pathol 2007 31 : 1089 93
18. Kovacs G, Akhtar M, Beckwith BJ et al. The Heidelberg classification of renal cell tumours. J Pathol 1997 183 : 131 3
19. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982 6 : 655 63
20. Bonsib SM, Gibson D, Mhoon M, Greene GF. Renal sinus involvement in renal cell carcinomas. Am J Surg Pathol 2000 24 : 451 8
21. Ries LA, Eisner MP, Kosary CL (eds) et al. SEER Cancer Statistics Review, 1975-2001. Bethesda, MD : National Cancer Institute. 2004. Available at: http://seer.cancer.gov/csr/1975-2001. Accessed 20 December 2007
22. Jacobsohn KM, Wood CG. Adjuvant therapy for renal cell carcinoma. Semin Oncol 2006 33 : 576 82
23. Beckwith JB. National Wilms Tumor Study: an update for pathologists. Pediatr Dev Pathol 1998 1 : 79 84
24. Bonsib SM. T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas. J Urol 2005 174 : 1199 202
25. Bonsib SM. The renal sinus is the principal invasive pathway: a prospective study of 100 renal cell carcinomas. Am J Surg Pathol 2004 28 : 1594 600
26. Bonsib SM. Renal lymphatics, and lymphatic involvement in sinus vein invasive (pT3b) clear cell renal cell carcinoma: a study of 40 cases. Mod Pathol 2006 19 : 746 53
27. Terrone C, Cracco C, Porpiglia F et al. Reassessing the current TNM lymph node staging for renal cell carcinoma. Eur Urol 2006 49 : 324 31